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Abstract 17 
The aim of this study was to examine the variation in antibiotic usage between 207 commercial 18 
sheep flocks using their veterinary practice prescribing records.  Mean and median prescribed mass 19 
per Population Corrected Unit (mg/PCU) was 11.38 and 5.95 respectively and closely correlated with 20 
Animal Defined Daily Dose (ADDD) 1.47(mean), 0.74(median) (R2 = 0.84, p<0.001). This is low in 21 
comparison with the suggested target (an average across all UK livestock sectors) of 50mg/PCU. In 22 
total, 80% of all antibiotic usage occurred in the 39% of flocks where per animal usage was greater 23 
than 9.0 mg/PCU. Parenteral antibiotics, principally oxytetracycline, represented 82% of the total 24 
prescribed mass, 65.5% of antibiotics (mg/PCU) were prescribed for the treatment of lameness. Oral 25 
antibiotics were prescribed to 49% of flocks, 64% of predicted lamb crop/farm. Lowland flocks were 26 
prescribed significantly more antibiotics than hill flocks. Variance partitioning apportioned 79% of 27 
variation in total antibiotic usage (mg/PCU) to the farm level and 21% to the veterinary practice 28 
indicating that veterinary practices have a substantial impact on overall antimicrobial usage. 29 
Reducing antibiotic usage in the sheep sector should be possible with better understanding of the 30 
drivers of high usage in individual flocks and of veterinary prescribing practices. 31 
Introduction 32 
Antibiotic usage in farmed species is under scrutiny because of increasing concern surrounding 33 
antimicrobial resistance, with imprudent patterns of prescribing and use representing a potential 34 
risk to human and animal health (O'Neill, 2015).  35 
Antibiotic usage is measured across the EU at a national level using the metric of total mass (mg) of 36 
any and all antibiotic active ingredients per Population Corrected Unit (mg/PCU). The PCU 37 
denominator is calculated as a standardised figure for each farmed species for breeding and 38 
slaughtered animals (EMA,  2013). There is significant variation between countries, with the UK’s 39 
usage at 62.1 mg/PCU ranked 15th out of 26 EU countries in order of highest antibiotic usage (EMA, 40 
2013).  41 
The UK government has identified reducing antibiotic usage as a priority and has adopted the 42 
mg/PCU metric to measure usage across all livestock sectors (UK Government, 2016) with a target 43 
for UK livestock production set at 50mg/PCU. The UK is the 4th largest livestock producer in the EU 44 
as calculated by PCU biomass (EMA, 2013) and the sheep industry in the UK is the largest in the EU. 45 
The sheep sector is also the largest single sector of UK livestock agriculture, representing 40% of the 46 
PCU biomass (EMA, 2013). For this reason, antibiotic usage in the UK sheep industry has a 47 
disproportionate impact on the total mg/PCU figure for the whole UK livestock sector.  48 
Species or sector specific targets are also expected to be set (UK Government, 2016), for which a 49 
detailed understanding of current usage patterns is required in order to make informed decisions in 50 
this area.  To understand how to reduce antibiotic usage in each sector, we need to understand the 51 
farm level usage, variability between farms within a species and reasons for use within farm. 52 
The aim of this study was to collate information from a large number of British sheep farms, 53 
primarily to evaluate the magnitude and variation in antibiotic usage and secondarily to assess 54 
factors that impact on farm level antibiotic usage.  55 
Methodology  56 
 57 
Farm selection criteria 58 
Two hundred and seven anonymised flock records were collated from a convenience sample of eight 59 
veterinary practices that were able to contribute sales and prescription records for all antibiotic 60 
products supplied to a minimum of ten sheep farm enterprises which met specific selection criteria. 61 
Practices were recruited with client farms located in the following regions: West Wales, Mid Wales, 62 
Central Scotland and the following English regions: South West, South East, West Midlands, East 63 
Midlands and North West.   Each practice provided details of all antibiotic products and quantity 64 
prescribed to all their sheep farming clients during the study period of August 2015-July 2016 along 65 
with flock level information on breeding flock size, flock type (categorised as Hill (18), Upland (25), 66 
Lowland (164)) and management system (Organic (11), Conventional (196)). A single, recent year 67 
was selected for analysis to reduce recall bias in the recording of the breeding ewe flock size, which 68 
were used as the denominator for antibiotic calculations.  Data were requested from farms that 69 
were sheep only holdings with a minimum of 100 breeding ewes; to avoid the risk of antibiotics 70 
being used in other species the study was restricted to farms exclusively with sheep. A minimum 71 
breeding ewe flock size was used to reduce the potential bias associated with unnecessarily large 72 
pack sizes of antibiotic products being supplied for small flocks, where unused product could 73 
represent a large proportion of the purchased total. The threshold also represented a reasonable cut 74 
off for commercial vs leisure/hobby flocks. The flock size ranged from 100 to 4000 ewes, with a 75 
mean and median size of 529 and 300 respectively. The threshold was selected based upon the 76 
maximum number of doses per product unit available in the UK.  77 
Calculation of antibiotic usage per population correction unit (PCU) 78 
The mass of antibiotic active ingredients per PCU was calculated for each prescribed product using 79 
the manufacturer supplied product specification and the ESVAC standard methodology (EMA, 2015) 80 
using approximate average body weights of adults (75kg) and weighted average weight for 81 
slaughtered lambs drawn from the Eurostat census. To calculate the lamb component of the PCU the 82 
mean rearing % of lambs per ewe (143.5%) in the reference period was estimated using the UK levy 83 
board benchmarking data (AHDB 2016) as a coefficient of the standard ESVAC lamb weight value 84 
(20kg). This metric was applied to all flocks in the study. 85 
The average ESVAC ewe and lamb weights were considered reasonable estimates for lowland flocks 86 
by the authors, however breeds used in hill farming in UK systems are generally smaller and less 87 
fecund than their lowland counterparts. To account for this potential bias, a sub-analysis was 88 
conducted where a separate ‘Hill-PCU’ was used as the denominator for antibiotic usage in hill flocks 89 
specifically. This was calculated based on a mature ewe body weight of 55kg, a lamb average body 90 
weight of 16kg and a rearing percentage of 115% (Welsh Farm Survey, 2016).  91 
Calculation of antibiotic usage by Defined Daily Doses (DDDvet), Defined Course Doses 92 
(DCDvet) and Animal-Defined Daily Dose (ADDD). 93 
Antibiotic usage at flock level was estimated using standardized methods as follows. The number of 94 
Defined Daily Doses (DDDvet) and Defined Course Doses (DCDvet) as Animal Defined Daily Dose 95 
(ADDD) per farm for the one year reference period were estimated for each farm. The breeding 96 
female population was used as the flock denominator and a standardized body weight of adult 97 
sheep of 75kg and was applied to convert the mg/kgBW into a per head unit in line with the 98 
standardised methodology set out by the ESVAC (EMA/710019/2014)(EMA, 2015). For oral and 99 
parenteral products DDDvet and DCDvet were calculated for each antibiotic product using either; (a) 100 
the licenced recommended maintenance dose for sheep where available, (b) the licenced 101 
recommended maintenance dose for cattle or pigs [dependent on the species licencing of the 102 
product] where the product used was not licenced for sheep but prescribed under the Veterinary 103 
Medicines Directorate ‘cascade’.  Topical preparations were excluded from the calculation of DDDvet 104 
and DCDvet in line with the ESVAC methodology. All products and preparations, including topical 105 
and oral preparations, were included in the mg/PCU metric. The ADDD metric was generated for 106 
comparison with mg/PCU and was calculated as previously described (Bos et al., 2013) and used for 107 
comparison of antibiotic usage in dairy herds (Kuipers, Koops, & Wemmenhove, 2016). An additional 108 
Lamb DCDvet metric was calculated for oral antibiotics licenced exclusively for neonatal lambs 109 
where dose was independent of body weight. These products were assigned a lamb DCDvet per 110 
animal rather than mg/kg body weight. In this study, the dose rates for these products were 111 
calculated on a fixed volume per animal as directed by manufacturer recommendations, rather than 112 
mg/kg bodyweight. The number of lamb DCDvet doses was then divided by the breeding ewe 113 
population per farm to generate an index of lamb doses per breeding ewe per flock.   114 
Statistical modelling 115 
A Linear regression model was used to assess the correlation between mg/PCU, ADDD (DDDvet and 116 
DCDvet) using MiniTab17 (Minitab 17 Inc, 2015). A multivariable regression model was developed 117 
with antibiotic use (mg/PCU) as the response variable. A multi-level structure was used to account 118 
for correlations in antibiotic use between farms, within a veterinary practice. The number of 119 
breeding ewes, farm type (organic, conventional) and farm stratification (Lowland, Upland, Hill) were 120 
forced into the model. Based on the a priori hypotheses of this study, all variables were retained in 121 
the model. The model was built using MLwiN version 2.36 (Charlton,  et al, 2017) and parameter 122 
estimates generated using iterative generalised least squares (IGLS). Model fit was assessed by 123 
examining q-q plots of residuals. The mg/PCU of antibiotic calculated for each farm were 124 
transformed to meet the assumptions of the multivariable regression model. The optimal 125 
transformation (mg/PCU to the power 0.28) was calculated using the boxcox function in the MASS 126 
package in R (Venables, W. N. & Ripley, 2002).  Variance partition coefficients (VPCs) were calculated 127 
using the final model to evaluate the proportion of unexplained variance occurring at both the farm 128 
and veterinary practice level. To facilitate interpretation of the final model, predictions were 129 
calculated by fixing explanatory variables at their mean value except the variable of interest.  130 
Predictions and their corresponding confidence interval estimates were back transformed to the 131 
mg/PCU scale.  132 
Antibiotic use by disease  133 
Analysis of the disease for which each antibiotic product was prescribed was possible for 24 flocks 134 
from one practice that routinely and accurately collected this information. Diseases were 135 
categorised for comparison of antibiotic usage by antibiotic class in mg/PCU. Disease incidence rates 136 
were estimated for the two most common prescribed reasons for antibiotic usage, using the DCDvet 137 
metric and the following assumptions: licenced dose rate was used for each dose, 75kg ewe body 138 
weight for each administered dose, all doses administered to ewes not lambs, zero wastage of 139 
antibiotic product. 140 
Results 141 
 142 
Distribution of total antibiotic usage per farm and comparison of metrics.  143 
Flock usage of antibiotics during the reference period ranged from 0 mg/PCU to 116.9 mg/PCU, with 144 
a mean of 11.38 (sd = 15.35)  and median of and 5.95 (IQR = 2.47 – 13.95) mg/PCU respectively. 4.3% 145 
of flocks recorded no antibiotic prescriptions during the reference period, while 1.9% of flocks 146 
recorded over 50 mg/PCU (Figure 1). In total, 80% of all antibiotic usage occurred in the 39% of 147 
flocks where per animal usage was greater than 9.0 mg/PCU 148 
Antibiotic usage at the farm level, using the ADDD metric, calculated using the DDDvet method 149 
indicated mean daily doses per animal of 1.47 (sd = 2.1)  and a median of 0.74 (IQR = 0.299 – 1.97). 150 
Mean and median usage as calculated by DCDvet per ewe per flock were 0.39 (sd = 0.53) and 0.20 151 
(IQR = 0.17, 0.26) respectively.  152 
Correlation between mg/PCU and ADDD using DDDvet for farms in this study was R2 = 0.84 153 
(P<0.001). The correlation between mg/PCU and ADDD using DCDvet was R2 = 0.77 (P<0.001). There 154 
was no significant correlation between Lamb DCDvet and any of the other metrics.  155 
 156 
Distribution of antibiotic usage by antibiotic group  157 
The mass of antibiotic products prescribed were ranked by antibiotic class (Table 1). The most 158 
commonly prescribed antibiotic was oxytetracycline, which comprised 57.4% of the total, followed 159 
by penicillin (including extended spectrum penicillins) 23.7%, aminoglycosides 10.7%, lincomycin 160 
4.7%, macrolides 1.7%, fluoroquinolones 0.5% and florfenicol 0.5%, with the remaining 0.9% being 161 
made up of cephalosporins, sulphonamides, trimethoprim and thiamphenicol.  162 
Distribution of antibiotic usage by route of administration 163 
Parenterally administered products represented 84.4% of the total mass used, whilst topical 164 
preparations represented 12.3% and oral represented 3.3% of the total mg/PCU (Table 1).  165 
Table 1 Percentage distribution of antibiotic prescriptions by mass (mg/PCU), antibiotic class and administration route per 166 
class across all farms.  167 
Antibiotic class 
 
 
Administration route (% of each class) % of Total 
mass of all 
classes 
Oral Parenteral Topical 
Oxytetracycline  91% 9% 57.4% 
Penicillin (inc extended 
spectrum) 
 98% 2% 23.6% 
Aminoglycoside 29% 66% 6% 10.7% 
Lincomycin    100% 4.7% 
Macrolides  60% 40% 1.7% 
Florfenicol  100%  0.5% 
Fluoroquinolones  38% 62% 0.5% 
Other 25% 55% 21% 0.9% 
 168 
 169 
Comparison of antibiotic group and route of administration between 1st and 4th 170 
quartile (high and low users) 171 
A comparison was made between the antibiotic usage of the upper quartile of flocks (Q1) (High 172 
users >13.95mg/PCU) and lower quartile flocks (Q4) (Low users < 2.47 mg/PCU). All the antibiotic 173 
classes were represented in the Q1 group of flocks, however the Q4 group used fewer antibiotic 174 
classes (oxytetracycline, penicillin (including extended spectrum), aminoglycosides, lincomycin). The 175 
total usage of all of these individual classes was significantly lower in Q4 compared to Q1. There was 176 
no significant difference in the proportional usage of antibiotic classes i.e. oxytetracycline was still 177 
the predominant antibiotic used, followed by penicillins, or in administration route.   178 
Seasonality of antibiotic usage by antibiotic group  179 
Antibiotic prescriptions were distributed throughout the year with a significant increase in spring 180 
along with a significant relative increase in the mg/PCU of penicillins and aminoglycosides (Figure 2). 181 
Oxytetracycline usage also increased in the spring but to a lesser extent than the increase observed 182 
with penicillin and the aminoglycosides. February was the only month in which oxytetracycline was 183 
surpassed by penicillins as the most commonly prescribed antibiotic class. All of the oral 184 
aminoglycoside antibiotics (neomycin and spectinomycin) were prescribed during the spring months, 185 
which coincides with the majority of lambing periods in UK flocks.  186 
 187 
Oral antibiotic usage in lambs  188 
In this study, 47% (95% CI: 41% - 62%) of flocks used oral antibiotics licenced for 189 
treatment/prophylaxis of colibacillosis in lambs. A further 2% of flocks, (4 farms from 2 practices) 190 
were prescribed oral antibiotic tablets. Of the lowland flocks sampled, 77% (95% CI: 42% - 90%) were 191 
prescribed oral antibiotics, whereas 44% (95% CI: 41% - 69%) of upland flocks and 25% (95% CI: 17% 192 
- 50%) of hill flocks were prescribed oral antibiotics. Licenced oral antibiotic products in this study 193 
were explicitly only approved for use in neonatal lambs. In those flocks using oral antibiotics, the 194 
mean number of lamb oral antibiotic doses prescribed per ewe per flock was 1.23 (95% CI: 0.034, 195 
5.181) and median of 0.92 (95% CI: 0.8, 1.2) doses per ewe per flock.   196 
Topical antibiotic preparations 197 
Topical antibiotic preparations were assigned to one of three catagories for comparison of the 198 
percentage prescribed total mass (mg/PCU) across all farms: ophthalmic preparations (4%), aerosol 199 
sprays (45%) and soluble powders (51%). Ophthalmic preparations were prescribed to 22% of farms, 200 
aerosol sprays were prescribed to 47% of farms and soluble powders were prescribed to 7% of 201 
farms. DDDvet and DCDvet metrics were not established for topical preparations in line with EMA 202 
standard methodology.  203 
Farm Stratification  204 
Considerable variation was observed in antibiotic usage between farms both within and between 205 
farm stratification categories (Figure 3). The distributions of mg/PCU within all categories of farm 206 
were positively skewed. 207 
 208 
Multivariable analysis: Influence of veterinary practice, management system and farm 209 
stratification on antibiotic use 210 
Accounting for influence of practice in the multi-level model structure, lowland farms were shown to 211 
use significantly more antibiotics (mg/PCU0.28) than hill farms (p=0.02), principally due to higher 212 
usage of parenteral oxytetracycline. When a ‘Hill-PCU’ coefficient (accounting for the lower body 213 
weights and lamb output) was applied to the antibiotic usage of hill flocks as opposed to the 214 
standard PCU coefficient appropriate to lowland flocks, a significantly lower antibiotic usage in hill 215 
flocks was still identified (p = 0.03). There was a non-significant trend for organic farms to use less 216 
antibiotic than conventional farms (p=0.06). In the final model, 21% of the unexplained variation in 217 
mg/PCU0.28 occurred between veterinary practices, with the remaining 79% of variation being 218 
between farms. Additional detail on model results are provided in supplementary material. 219 
 220 
Distribution of antibiotic usage by clinical diagnosis 221 
A subset analysis of antibiotic class prescription patterns by clinical diagnosis was conducted on the 222 
data supplied by one veterinary practice with unusually detailed records of all antibiotics prescribed. 223 
Analysis of these 24 flocks data revealed that lameness accounted for 65.5% of antibiotics prescribed 224 
by this practice (Table 2) and oxytetracycline was the most commonly prescribed antibiotic 225 
accounting for 63.5% of the total, followed by penicillins (26.8% of total). Penicillins were prescribed 226 
for the widest range of clinical diagnoses (9 of 11 disease categories, Table 2), while oxytetracycline 227 
was prescribed for 4 of 11 categories and 85.1% of all oxytetracycline was prescribed for treatment 228 
of lameness (Table 2). The mean proportion of oxytetracycline prescribed for the treatment of 229 
lameness per farm was 91% (95% CI: 81%, 99%). 230 
Table 2.  Antibiotic prescription patterns by diagnosis from a subset of 24 flocks supplied by one veterinary practice with 231 
unusually detailed prescription records. The proportions of antibiotics per class prescribed for each diagnosis are stated as a 232 
percentage of the total prescribed for that antibiotic class. The number of flocks prescribed a given class for a given 233 
diagnosis is stated in brackets.  The Lameness category includes Contagious Ovine Digital Dermatitis, Footrot and 234 
Interdigital Dermatitis.  235 
Treatment 
Diagnosis 
Aminoglycosides 
Penicillins 
(including 
extended 
spectrum) 
Macrolides Oxytetracycline Lincomycin 
% Total 
mg/PCU 
by cause 
Abortion    5.4% (1)  3.2% 
Colibacillosis 43.4%  (11)     2.2% 
Lambing 
(inc dystocia, 
prolapse) 
 29.4%  (18)    9.7% 
Lameness (inc 
CODD, FR, ID) 
24.6%  (1) 34.5% (13) 75.6%  (10) 85.1% (23) 100.0% (4) 65.5% 
Listeriosis  0.3%  (1)    0.1% 
Mastitis  10.3% (4)    3.4% 
Metritis  0.4%  (1)    0.1% 
Ophthalmic  1.7%  (5)  9.2% (4)  6.0% 
Pneumonia  0.4%  (1)  0.3%  (1)  0.3% 
Polyarthritis 32.0%  (2) 18.8%  (9) 24.4%  (4)   8.2% 
Not recorded  4.3%  (5)    1.4% 
% Total mg/PCU 
by antibiotic 
class 
2.0% 26.8% 6.3% 63.5% 1.3%  
 236 
Incidence of lameness treatments and treatments associated with lambing were estimated using the 237 
DCDvet for each flock (Table 3). DCDvet based estimates of lameness incidence between farms 238 
indicate a wider and higher range of treatment rates for lameness with a median of 29.6 ewe 239 
treatment DCDvet per 100 ewes per year.  240 
Table 3 Disease incidence estimates for lameness and lambing associated events based upon prescribed antibiotic DCDvet 241 
values for parenteral antibiotics prescribed for each.  242 
 Mean  Median Range   
Parenteral treatments 
for lameness 
42.7 ewe treatment 
DCDvet per 100 ewes per 
year 
29.6 ewe treatment DCDvet 
per 100 ewes per year 
9.6 – 67.0 
Parenteral treatments 
for lambing associated 
events (including 
dystocia, prolapse) 
7.8 ewe treatment 
DCDvet per 100 ewes per 
year  
6.8 ewe treatment DCDvet 
per 100 ewes per year  
3.2 – 10.3 
 243 
Discussion 244 
 245 
The results of this study suggest that antibiotic use in all sectors and management systems of the UK 246 
sheep industry is very low in comparison with the overall average of 56mg/PCU recorded across all 247 
UK livestock sectors in 2015 (UK government VARSS 2015).  The relatively low usage of antibiotics in 248 
the sheep sector should not give rise to complacency. This study highlights a number of areas where 249 
potential improvements in our use and monitoring of antibiotics can be made.  250 
If antibiotic usage is to be reduced in line with the stated EU and UK policy statements (UK 251 
Government, 2016) then it would be logical to target those diseases which drive highest usage with a 252 
‘Refine, Reduce, Replace’ strategy, whilst keeping in mind the other priorities, principally animal 253 
welfare. In identifying the most appropriate strategy for minimising any potential antibiotic 254 
resistance selection risk, the metric used needs to be appropriate. It would be counterproductive if a 255 
targeted adoption of one metric, led inadvertently, to antibiotic use patterns that did not reflect the 256 
best evidence based clinical practice or neglected high risk antibiotic use.  257 
It should be noted that the dominance of parenteral oxytetracycline and to a lesser extent penicillins 258 
identified in this study resulted in a close correlation between the two main metrics for antibiotic 259 
usage; Population Corrected Unit (PCU) and Animal Defined Daily Dose ADDD (DCDvet/DDDvet). The 260 
close correlation between mg/PCU and ADDD (DDDvet/DCDvet) in the sheep sector may be very 261 
helpful in simplifying monitoring of antibiotic usage, however the use of oral aminoglycosides in 262 
neonatal lambs and the use of soluble antibiotic powders for topical use in footbaths or hand sprays 263 
to control lameness (particularly contagious ovine digital dermatitis (CODD)) present two important 264 
challenges that may be obscured by the scale of oxytetracycline use. Both of these practices have 265 
the potential to subject a larger proportion of the flock, as well as the wider farm environment, to 266 
antibiotic resistance selection, than targeted individual parenterally administered treatments.  267 
Overall, 79% of the variation in antibiotic usage observed between flocks was attributable to 268 
differences between farms. These are likely to include a combination of biological and management 269 
differences, which influence the force of infection and genetic differences in disease susceptibility to 270 
infection. However, the between farm variation in antibiotic use will also likely be influenced by the 271 
priorities, understanding and attitudes of the farmers and shepherds responsible. Previous studies 272 
have demonstrated differences in attitude to population health management  between sheep and 273 
pig farmers (Garforth, Bailey, & Tranter, 2013).  In the context of antibiotic usage this study has 274 
demonstrated that flock type (Hill, Upland, Lowland) was significantly associated with different 275 
levels of antibiotic use and the basis for these differences warrant further investigation.  276 
There was an important further 21% of variation attributable to the veterinary practice serving the 277 
individual flocks after the effects of stratification, region, flock size and management system were 278 
accounted for. This suggests there is an important influence of practice prescribing policy and 279 
practice culture on the quantity of antibiotics prescribed for sheep. Reasons for these differences 280 
cannot be elucidated from the current study and this would be a worthwhile topic for future 281 
research.  Surveys that rely on the voluntary contribution of data from participants (veterinary 282 
practices in this case) are subject to bias and it is unclear the extent to which this convenience 283 
sample is representative of the national flock. With the current absence of a universal, robustly 284 
audited, mandatory reporting system of antibiotic use/prescription, these study findings represent 285 
initial data that may indicate current prescription patterns in the UK sheep industry. Further studies 286 
that incorporate true random sampling would be of value. 287 
The subset analysis of antibiotic prescriptions per disease process from one practice (24 flocks) 288 
suggested that the pattern of antibiotic usage across the 24 flocks was comparable to the dataset as 289 
a whole in terms of overall usage per flock, relative usage by antibiotic classes and seasonality of 290 
usage. It would therefore seem reasonable to conclude that some useful estimates of the disease 291 
diagnosies underpinning antibiotic usage may be drawn from this subset of data. Principally the 292 
treatment of lameness was the most common reason for the use of antibiotics (mainly 293 
oxytetracycline) in sheep flocks, accounting for approximately 65 % of total mg/PCU. This result is 294 
not surprising given the prevalence of footrot, interdigital dermatitis and contagious ovine digital 295 
dermatitis. However, since important variation between practices in prescribing policies was also 296 
identified in this study, it should also be recognised that records from one veterinary practice may 297 
not be representative of practices in general.   298 
Prompt parenteral antibiotic treatment (PAT) forms part of the accepted best practice guidelines for 299 
the control of footrot (Kaler et al, 2010) and has been shown to reduce the prevalence of footrot in 300 
flocks. In many upland and hill flocks, where grazing management is more extensive and PAT is not 301 
practical, regular periodic treatment with parenteral antibiotics has also been suggested to be 302 
effective in reducing lameness prevalence (Angell & Duncan, 2015). The authors suggest that some 303 
of the significant variation observed in this study between lowland and hill flocks in the usage of 304 
oxytetracycline may be due to the greater difficultly in adopting PAT protocols for lameness 305 
management in comparison to their lowland counterparts. Infection pressure and risk of clinical 306 
disease may also vary between these hill and lowland farms. 307 
Whilst lameness prevalence is referred to widely (J. R. Winter, Kaler, Ferguson, Kilbride, & Green, 308 
2015), there is little published data on the incidence rates of lameness in commercial flocks under 309 
typical management conditions. The extrapolated treatment rate calculated in this study from the 310 
subset of 24 flocks with detailed diagnosis data on each antibiotic product unit is an attempt to use 311 
readily available data to provide a crude estimate of treatment rate as a proxy for disease incidence. 312 
Accepting that the treatment rate measure used makes several key assumptions as detailed 313 
previously, the high median treatment rates of 29.6 cases per 100 ewes per year and wide range 314 
between farms may represent a reasonable benchmark when considering appropriate strategies for 315 
lameness control.   316 
Whilst the use of parenteral oxytetracycline would seem most plausibly attributed to its perpetual 317 
use in the control of infectious lameness a small seasonal increase observed in February and March 318 
could be attributed, at least in part, to the prophylactic or metaphylactic use in the control of 319 
Chlamydophila abortus. This use of oxytetracycline was estimated in this study at 5% of flocks (table 320 
2) per year and by others as high as 10% of flocks per year (Lovatt et al, unpublished data). 321 
Oral aminoglycosides are licenced for the treatment and/or prophylaxis of enteric E.coli infections in 322 
neonatal lambs. The ESVAC methodology for calculating DDDvet and DCDvet values for oral 323 
antibiotics dramatically underestimate the number of individuals and thus the proportion of the 324 
population that are treated.  For this reason it seems logical that neonatal antibiotic preparations 325 
should be recorded as a ‘per animal’ dose rather than as mg/kg body weight. In this study, 49% of 326 
farms were prescribed oral antibiotics.  Extrapolating from the UK benchmarked mean rearing 327 
percentage of lambs per ewe (143.5%), the mean and median doses per lamb reared per flock using 328 
oral antibiotics is approximately 0.86 and 0.64 respectively. 329 
The most common aminoglycoside antibiotic preparation prescribed in this study is also licenced for 330 
use in piglets. In piglets, the exposure of the developing gastrointestinal flora to antibiotics has been 331 
shown to have enduring effects on the microbiota (Schokker et al, 2015). It is unclear if similar 332 
results would be expected in ruminant species. It has been shown that there is significant variation 333 
in microbiota between calves from different beef herds (Weese & Jelinski, 2017) and early life 334 
exposure of calves to antibiotics was hypothesised as a potential contributory factor. More research 335 
is required to understand the dynamics of the microbiota development in lambs and what affect 336 
peri-natal antibiotic treatment may have on antimicrobial resistance as well as their long term 337 
health.  338 
Topical use of antibiotics presents a different but no less important challenge. Topical antibiotic 339 
preparations are excluded from ESVAC DDDvet/DCDvet metrics, however in the sheep and cattle 340 
industries, these products are commonly used both in antibiotic footbaths and also as topical sprays, 341 
primarily for the treatment of pathogens causing lameness. A wide range of soluble antibiotic 342 
products including macrolides, aminoglycosides, lincomycin and fluoroquinolones were prescribed 343 
to a small proportion of flocks (7%). In the authors’ experience, these products, licenced for oral 344 
administration to pigs, poultry and calves, are prescribed overwhelmingly for the treatment and 345 
control of lameness caused by CODD. The use of such preparations by this route for treating 346 
lameness is a well-established clinical approach for CODD in sheep and the cattle equivalent 347 
condition, digital dermatitis, in the UK and internationally (Laven & Logue, 2006; A. C. Winter, 348 
2011).In the case of CODD in particular, there is no published evidence to support this form of use, 349 
whilst the evidence to support the use of antibiotic footbaths to control of digital dermatitis in cattle 350 
is weak. The lack of an evidence base to guide decisions on dose rate and effective application 351 
protocols raises the possibility that sub-therapeutic dosing may be common in this clinical scenario, 352 
whilst spent footbath solutions are commonly discharged into slurry or the environment. It must be 353 
recognised that in addition to the causative pathogens, a wide variety of other bacterial species on 354 
the foot and in the soil environment will also be exposed as a result of the use of these antibiotic 355 
products in this way.  This is an undesirable and potentially imprudent use of antibiotics, which is 356 
difficult to justify unless substantially better welfare outcomes can be demonstrated compared to 357 
targeted treatment with parenteral antibiotics, which is known to be highly efficacious (Duncan et al. 358 
2011, 2012, Angell et al,  2014, Angell & Duncan, 2015). CODD is estimated to affect approximately 359 
35% of UK flocks (Angell et al, 2014) Assuming a similar prevalence of CODD for the flocks in this 360 
study, it can be inferred that the majority of CODD affected flocks are not using antibiotic footbaths 361 
to control this disease on a regular basis.  362 
It cannot be assumed that low antibiotic usage correlates with low disease or good welfare and 363 
there is a great danger in conflating the two measures. Low, targeted usage of antibiotics in all 364 
veterinary species is desirable but this must be balanced with concern for animal welfare and 365 
sustainable productivity. This study has demonstrated significant variation in antibiotic usage 366 
between farms and between veterinary practices. Further research is required to understand the 367 
biological, managemental and physiological drivers of antibiotic prescription and use among sheep 368 
farmers and their prescribing veterinary surgeons in order to achieve a sustainable reduction in 369 
antibiotic use. 370 
 371 
Figures 372 
 373 
Figure 1  Distribution of antibiotic usage in total mg/PCU from 207 individual sheep flocks in England, 374 
Wales and Scotland compiled from prescribing records of eight veterinary practices over a 12 month 375 
period from 1st August 2015 to 31st July 2016. 376 
 377 
Figure 2  Percentage of total antibiotic usage mg/PCU per month for all flocks by antibiotic class. 378 
 379 
Figure 3 Distribution of flock antibiotic usage in mg/PCU by farm stratification. Box indicates the 380 
interquartile range. Whiskers indicate upper and lower quartiles excluding outliers calculated as 381 
those > 1.5 IQR from Q1/Q2 or Q3/Q4 boundary. Median is identified by horizontal line, mean is 382 
identified by black diamond. 383 
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